Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives.
D000818:Animals; D001241:Aspirin / Q000494:pharmacology; D001792:Blood Platelets / Q000276:immunology / Q000502:physiology*; D001986:Bronchial Spasm / Q000139:chemically induced* / Q000503:physiopathology; D011464:Epoprostenol / Q000494:pharmacology; D066298:In Vitro Techniques; D008244:Lysophosphatidylcholines / Q000494:pharmacology*; D010972:Platelet Activating Factor; D010974:Platelet Aggregation / Q000187:drug effects; D011453:Prostaglandins / Q000096:biosynthesis* / Q000502:physiology; D011817:Rabbits; D013928:Thromboxane A2 / Q000097:blood; D013997:Time Factors
D008244:Lysophosphatidylcholines; D010972:Platelet Activating Factor; D011453:Prostaglandins; D013928:Thromboxane A2; D011464:Epoprostenol; D001241:Aspirin